Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;26(12):101290.
doi: 10.1016/j.gim.2024.101290. Epub 2024 Oct 5.

A systematic framework for selecting gene-condition pairs for inclusion in newborn sequencing panels: Early Check implementation

Affiliations

A systematic framework for selecting gene-condition pairs for inclusion in newborn sequencing panels: Early Check implementation

Heidi L Cope et al. Genet Med. 2024 Dec.

Abstract

Purpose: Research is underway worldwide to investigate the feasibility, acceptability, and utility of sequencing-based newborn screening. Different methods have been used to select gene-condition pairs for screening, leading to highly inconsistent gene lists across studies.

Methods: Early Check developed and utilized actionability-based frameworks for evaluating gene-condition pairs for inclusion in newborn panels (panel 1-high actionability, panel 2-possible actionability). A previously developed framework, the Age-based Semi Quantitative Metric (ASQM), was adapted. Increasing ASQM scores, with a maximum of 15, suggest greater actionability. Wilcoxon tests were performed to compare panel 1 gene-condition pairs on the Recommended Uniform Screening Panel (RUSP) with non-RUSP pairs.

Results: In our first round of assessment, Early Check identified 178 gene-condition pairs for inclusion in panel 1 and 29 for panel 2. Median ASQM scores of RUSP conditions on panel 1 was 12 (range 4 to 15) and non-RUSP was 13 (range 9 to 15). Median scores for panel 2 was 10 (range 6 to 14).

Conclusion: The Early Check frameworks provide a transparent, semiquantitative, and reproducible methodology for selecting gene-condition pairs for newborn screening sequencing pilot studies that may inform future integration of genomic sequencing into population-level newborn screening. Collaborative efforts among newborn sequencing studies to establish shared criteria is needed to enhance cross-study comparisons.

Keywords: Clinical actionability; Early Check; Genome sequencing; Newborn screening; Newborn sequencing.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Rebekah S. Zimmerman, Sharon F. Suchy, Amber Begtrup, Katherine G. Langley, Kristin G. Monaghan, Christina Kraczkowski, Kathleen S. Hruska, and Paul Kruszka were employees of GeneDx, LLC at the time of this study. All other authors declare no conflicts of interest.

References

    1. Berg JS, Powell CM. Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening. Cold Spring Harb Perspect Med. 2015;5(12). - PMC - PubMed
    1. Berg JS, Agrawal PB, Bailey DB Jr., Beggs AH, Brenner SE, Brower AM, et al. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017;139(2). - PMC - PubMed
    1. Bick D, Ahmed A, Deen D, Ferlini A, Garnier N, Kasperaviciute D, et al. Newborn screening by genomic sequencing: opportunities and challenges. Int J Neonatal Screen. 2022;8(3). - PMC - PubMed
    1. Woerner AC, Gallagher RC, Vockley J, Adhikari AN. The use of whole genome and exome sequencing for newborn screening: challenges and opportunities for population health. Front Pediatr. 2021;9:663752. - PMC - PubMed
    1. Stark Z, Scott RH. Genomic newborn screening for rare diseases. Nat Rev Genet. 2023;24(11):755–66. - PubMed

MeSH terms

LinkOut - more resources